Superworth

Acadia Healthcare ACHC

Medical - Care Facilities, Healthcare
$31.51
−1.16%
Market cap
$2.9B
PE
n/m
a loss over the last year
Forward PE
n/m
not a meaningful number
Price to sales
0.9×
EV/EBIT
4.7×
Revenue, 12 months
$3.4B
+4% on a year ago
Net margin
−33.4%
Free cash flow yield
−4.6%

Acadia Healthcare trades at 0.9× sales. Its trailing earnings are negative, so it has no PE. Revenue was $3.4B over the last twelve months, up 4% on a year earlier with a −33% net margin.

Charts

Financials

Income statement for ACHC, by quarter
Income statementQ3 FY23Q4 FY23Q1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26
$750.3M+13%$742.8M+10%$768.1M+9%$796M+9%$815.6M+9%$774.2M+4%$770.5M+0%$869.2M+9%$851.6M+4%$821.5M+6%$828.8M+8%$865.8M−0%
−$266.7M$100.4M−7%$126.1M+19%$135.6M+16%$128.5M$68.1M−32%$43.9M−65%$85.1M−37%$76.6M−40%−$1.1B$49.3M+12%$60.2M−29%
Interest expense$20.7M+15%$20.5M+6%$27.2M+36%$29.2M+40%$29.9M+44%$30.1M+47%$29.2M+7%$35.1M+21%$36.6M+22%$37.9M+26%$38.3M+31%$38.2M+9%
Pre-tax income−$287.4M$80M−9%$98.8M+15%$106.5M+10%$98.6M$38M−53%$13.5M−86%$50M−53%$40M−59%−$1.2B$11M−19%$22M−56%
−$71.9M$20.2M−19%$20.1M+5%$25.6M+12%$27.2M$4.5M−78%$4.4M−78%$12.1M−53%$1.7M−94%$7.8M+75%$6.5M+48%$9.7M−19%
Net income−$217.7M$57.7M−6%$76.4M+16%$78.5M+9%$68.1M$32.6M−44%$8.4M−89%$30.1M−62%$36.2M−47%−$1.2B$4.1M−51%$10.9M−64%
−$2.39$0.63−6%$0.83+15%$0.85+8%$0.74$0.35−44%$0.09−89%$0.33−61%$0.40−46%−$13.02$0.05−44%$0.12−64%
91.2M−1%91.2M+0%92M+1%92M+1%92.2M+1%91.9M+1%92M+0%90.4M−2%90.6M−2%90.4M−2%90.9M−1%91.4M+1%

Operating income: 64 periods, Q3 FY10 to Q2 FY26: not printed by the filing, worked out from its own lines.

EPS, diluted: 8 periods, Q4 FY10 to Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: 10 periods, Q4 FY10 to Q4 FY24: share-days: the 12-month average less the 9-month, weighted by days. 5 periods, Q4 FY11 to Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days. Q4 FY16: the earlier year to date counted no dilution: the quarter's basic count plus the later year to date's dilution.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Care Facilities nearest Acadia Healthcare's size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
ACHCAcadia Healthcare$2.9Bn/m19.4×0.9×+4%−33.4%
AVAHAveanna Healthcare$2.9B10.9×21.8×1.1×+20%10.6%
PRVAPrivia Health$2.9B107×158×1.2×+24%1.2%
MDPediatrix Medical$2.4B14.0×13.4×1.2×+1%9.0%
NHCNational Healthcare$3.7B26.5×21.4×2.4×+7%9.0%
ADUSAddus HomeCare$2.3B21.4×32.4×1.5×+16%7.1%
PGNYProgyny$2.2B31.5×55.1×1.7×+6%6.0%
OPCHOption Care Health$4.7B23.5×26.4×0.8×+6%3.7%
LFSTLifeStance Health$4.9B99.5×142×3.1×+20%3.2%
HCSGHealthcare Services$1.7B14.7×26.1×0.9×+4%6.6%
ARDTArdent Health$1.7B22.3×8.5×0.3×+3%1.2%
Peer median$2.6B22.9×26.3×1.2×+6%6.3%

Investors who own it

Investors we follow who held Acadia Healthcare at the end of Jun 30, 2026, from their 13F filings.

More on Acadia Healthcare

Each number over time

Where it ranks

Its groups

About

Industry
Medical - Care Facilities
Sector
Healthcare

Valuation data, not investment advice. Prices as of .